Sichuan Kelun Pharmaceutical Co Ltd (002422) — Capital Reinvestment Ratio
Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Capital Reinvestment Ratio of 0.73x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥537.31 Million) in capital expenditures (CN¥393.58 Million). See 002422 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sichuan Kelun Pharmaceutical Co Ltd Capital Reinvestment Ratio (2007–2025)
This chart tracks Sichuan Kelun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods. Check 002422 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Year-by-year Capital Reinvestment Ratio for Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. For live market cap and broader valuation context, see how much is Sichuan Kelun Pharmaceutical Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.61x | CN¥2.64 Billion | CN¥1.62 Billion | ▲ +64.4% |
| 2024 | 0.37x | CN¥4.49 Billion | CN¥1.68 Billion | ▲ +12.7% |
| 2023 | 0.33x | CN¥5.34 Billion | CN¥1.77 Billion | ▲ +15.7% |
| 2022 | 0.29x | CN¥3.13 Billion | CN¥896.02 Million | ▼ -17.7% |
| 2021 | 0.35x | CN¥2.85 Billion | CN¥990.56 Million | ▼ -37.3% |
| 2020 | 0.55x | CN¥2.22 Billion | CN¥1.23 Billion | ▼ -7.6% |
| 2019 | 0.60x | CN¥2.22 Billion | CN¥1.33 Billion | ▲ +33.4% |
| 2018 | 0.45x | CN¥2.95 Billion | CN¥1.33 Billion | ▼ -63.3% |
| 2017 | 1.23x | CN¥1.20 Billion | CN¥1.48 Billion | ▲ +54.7% |
| 2016 | 0.79x | CN¥1.73 Billion | CN¥1.37 Billion | ▼ -46.5% |
| 2015 | 1.48x | CN¥1.24 Billion | CN¥1.84 Billion | ▼ -34.4% |
| 2014 | 2.26x | CN¥1.22 Billion | CN¥2.76 Billion | ▲ +5.2% |
| 2013 | 2.15x | CN¥1.05 Billion | CN¥2.26 Billion | ▼ -68.8% |
| 2012 | 6.89x | CN¥402.77 Million | CN¥2.77 Billion | ▲ +17.8% |
| 2011 | 5.85x | CN¥342.93 Million | CN¥2.00 Billion | ▲ +34.8% |
| 2010 | 4.34x | CN¥149.29 Million | CN¥647.22 Million | ▲ +294.8% |
| 2009 | 1.10x | CN¥250.69 Million | CN¥275.29 Million | ▲ +7.1% |
| 2008 | 1.02x | CN¥221.08 Million | CN¥226.58 Million | ▼ -1.4% |
| 2007 | 1.04x | CN¥168.42 Million | CN¥175.05 Million | — |